BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/14/2022 12:54:50 PM | Browse: 804 | Download: 2198
 |
Received |
|
2022-06-08 16:16 |
|
Peer-Review Started |
|
2022-06-08 16:19 |
|
First Decision by Editorial Office Director |
|
2022-08-20 00:54 |
|
Return for Revision |
|
2022-08-20 14:56 |
|
Revised |
|
2022-09-04 09:30 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-09-13 03:47 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-09-14 16:44 |
|
Articles in Press |
|
2022-09-14 16:44 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-27 15:57 |
|
Publish the Manuscript Online |
|
2022-10-14 12:54 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xue-Song Bai, Sheng-Nan Zhou, Yi-Qun Jin and Xiao-Dong He |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| China Academy of Medical Science Innovation Fund for Medical Sciences, CIFMS |
2021-I2M-1-022-2021-S4 |
|
| Corresponding Author |
Xiao-Dong He, Doctor, MD, Professor, Department of General Surgery, Peking Union Medical College Hospital, China Academy of Medical Science & Peking Union Medical College, No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730, China. hxdpumch@163.com |
| Key Words |
Advanced biliary tract cancer; Targeted therapy; Chemotherapy; Meta-analysis; Randomized controlled trial; First-line treatment |
| Core Tip |
The clinical efficacy of adding targeted agents to first-line treatment of biliary tract cancer (BTC) remains unclear. Our study is the first meta-analysis of randomized clinical trials to evaluate the efficacy of the combination of targeted therapy (TT) with standard chemotherapy (CT) as first-line treatment in patients with advanced BTC. We assessed the efficacy of combined TT and CT in terms of objective response rate, progression-free survival and overall survival. Subgroup analyses were conducted based on different targeted agents, CT regimens and tumor locations. |
| Publish Date |
2022-10-14 12:54 |
| Citation |
Bai XS, Zhou SN, Jin YQ, He XD. Combining of chemotherapy with targeted therapy for advanced biliary tract cancer: A systematic review and meta-analysis. World J Gastrointest Oncol 2022; 14(10): 2061-2076 |
| URL |
https://www.wjgnet.com/1948-5204/full/v14/i10/2061.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v14.i10.2061 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
